On Tuesday, Vivos Therapeutics Inc (NASDAQ: VVOS) opened higher 10.90% from the last session, before settling in for the closing price of $3.12. Price fluctuations for VVOS have ranged from $1.91 to $6.28 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 6.23% annually for the last half of the decade. Company’s average yearly earnings per share was noted 81.87% at the time writing. With a float of $4.59 million, this company’s outstanding shares have now reached $4.77 million.
In an organization with 114 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 59.74%, operating margin of -84.75%, and the pretax margin is -86.19%.
Vivos Therapeutics Inc (VVOS) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Vivos Therapeutics Inc is 22.02%, while institutional ownership is 12.19%.
Vivos Therapeutics Inc (VVOS) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.41 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 81.87% per share during the next fiscal year.
Vivos Therapeutics Inc (NASDAQ: VVOS) Trading Performance Indicators
Check out the current performance indicators for Vivos Therapeutics Inc (VVOS). In the past quarter, the stock posted a quick ratio of 1.44. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.95, a number that is poised to hit -0.40 in the next quarter and is forecasted to reach -1.06 in one year’s time.
Technical Analysis of Vivos Therapeutics Inc (VVOS)
Let’s dig in a bit further. During the last 5-days, its volume was 0.39 million. That was better than the volume of 0.27 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 19.49%. Additionally, its Average True Range was 0.41.
During the past 100 days, Vivos Therapeutics Inc’s (VVOS) raw stochastic average was set at 30.46%, which indicates a significant decrease from 35.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 97.78% in the past 14 days, which was higher than the 85.82% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.42, while its 200-day Moving Average is $3.07. However, in the short run, Vivos Therapeutics Inc’s stock first resistance to watch stands at $3.66. Second resistance stands at $3.87. The third major resistance level sits at $4.16. If the price goes on to break the first support level at $3.16, it is likely to go to the next support level at $2.87. The third support level lies at $2.66 if the price breaches the second support level.
Vivos Therapeutics Inc (NASDAQ: VVOS) Key Stats
There are currently 5,890K shares outstanding in the company with a market cap of 20.38 million. Presently, the company’s annual sales total 13,800 K according to its annual income of -13,580 K. Last quarter, the company’s sales amounted to 3,860 K and its income totaled -2,620 K.
